Table-II.
Frequency of mutations in MPN patients.
| JAK2 V617F | JAK2 exon 12 | cMPL | CALR | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Total No. of Patients | Negative | Positive | Negative | Positive | Negative | Positive | Negative | Positive |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| PV | 60 | 29/60 (48.3) | 31/60 (51.7) | 60/60 (100) | 0/60 (0) | 60/60 (100) | 0/60 (0) | 60/60 (100) | 0/60 (0) |
| ET | 30 | 26/30 (86.7) | 4/30 (13.3) | 30/30 (100) | 0/30 (0) | 30/30 (100) | 0/30 (0) | 25/30 (83.3) | 5/30 (16.7) |
| PMF | 69 | 43/69 (62.3) | 26/69 (37.7) | 69/69 (100) | 0/69 (0) | 69/69 (100) | 0/69 (0) | 68/69 (98.6) | 1/63 (1.4) |
| Total | 159 | 98 | 61 | 159 | 0 | 159 | 0 | 153 | 6 |
| P-value | 0.001 | 0.15 | --- | 0.0001 | |||||
Note: Chi-square test was applied. P < 0.05 was statistically significant.